Other activity disclosed
Sciences Roivant
Director
Common Shares
- Value context
- $44.84M
- Reported price
- $5.00 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Arbutus Biopharma Corp
Last 30 daysNo qualifying insider buying. No qualifying insider sales.
Showing the first 6 of 20 trades on this page.
Director
Common Shares
President and CEO
Common Shares
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
President and CEO
Common Shares
President and CEO
Common Shares
President and CEO
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
President and CEO
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Financial Officer
Common Shares
Chief Financial Officer
Common Shares
Chief Financial Officer
Common Shares
Chief Financial Officer
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Financial Officer
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Common Shares
Director
Common Shares
Director
Common Shares
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Common Shares
Director
Common Shares
Director
Common Shares
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Director | Common SharesDisposition to issuer | 8,967,383$5.00 / share | $44.84M | Oct 1Filed Oct 5 · 4d later | SEC filing |
| President and CEO | Common SharesOption exercise or conversion | 116,408$3.20 / share | $372.51K | Sep 18Filed Sep 23 · 5d later | SEC filing |
| President and CEO | Common SharesOption exercise or conversion | 10,456$4.39 / share | $45.9K | Sep 18Filed Sep 23 · 5d later | SEC filing |
| President and CEO | Common SharesExercise-price or tax withholding | 82,527$5.07 / share | $418.41K | Sep 18Filed Sep 23 · 5d later | SEC filing |
| President and CEO | Stock Option (Right to Buy)Option exercise or conversion | Derivative units116,408$3.20 exercise / conversion price | Not a separate purchase | Sep 18Filed Sep 23 · 5d later | SEC filing |
| President and CEO | Stock Option (Right to Buy)Option exercise or conversion | Derivative units10,456$4.39 exercise / conversion price | Not a separate purchase | Sep 18Filed Sep 23 · 5d later | SEC filing |
| Chief Financial Officer | Common SharesOption exercise or conversion | 265,625$3.49 / share | $927.03K | Sep 18Filed Sep 23 · 5d later | SEC filing |
| Chief Financial Officer | Common SharesOption exercise or conversion | 27,475$4.39 / share | $120.62K | Sep 18Filed Sep 23 · 5d later | SEC filing |
| Chief Financial Officer | Common SharesExercise-price or tax withholding | 206,637$5.07 / share | $1.05M | Sep 18Filed Sep 23 · 5d later | SEC filing |
| Chief Financial Officer | Stock Option (Right to Buy)Option exercise or conversion | Derivative units265,625$3.49 exercise / conversion price | Not a separate purchase | Sep 18Filed Sep 23 · 5d later | SEC filing |
| Chief Financial Officer | Stock Option (Right to Buy)Option exercise or conversion | Derivative units27,475$4.39 exercise / conversion price | Not a separate purchase | Sep 18Filed Sep 23 · 5d later | SEC filing |
| Director | Common SharesOption exercise or conversion | 52,533$3.34 / share | $175.46K | Sep 18Filed Sep 23 · 5d later | SEC filing |
| Director | Common SharesOption exercise or conversion | 78,800$4.24 / share | $334.11K | Sep 18Filed Sep 23 · 5d later | SEC filing |
| Director | Common SharesExercise-price or tax withholding | 100,508$5.07 / share | $509.58K | Sep 18Filed Sep 23 · 5d later | SEC filing |
| Director | Stock Option (Right to Buy)Option exercise or conversion | Derivative units52,533$3.34 exercise / conversion price | Not a separate purchase | Sep 18Filed Sep 23 · 5d later | SEC filing |
| Director | Stock Option (Right to Buy)Option exercise or conversion | Derivative units78,800$4.24 exercise / conversion price | Not a separate purchase | Sep 18Filed Sep 23 · 5d later | SEC filing |
| Director | Common SharesOption exercise or conversion | 52,533$3.20 / share | $168.11K | Sep 18Filed Sep 23 · 5d later | SEC filing |
| Director | Common SharesOption exercise or conversion | 78,800$4.24 / share | $334.11K | Sep 18Filed Sep 23 · 5d later | SEC filing |
| Director | Common SharesExercise-price or tax withholding | 99,057$5.07 / share | $502.22K | Sep 18Filed Sep 23 · 5d later | SEC filing |
| Director | Stock Option (Right to Buy)Option exercise or conversion | Derivative units52,533$3.20 exercise / conversion price | Not a separate purchase | Sep 18Filed Sep 23 · 5d later | SEC filing |
Showing the latest 20 of 23 trades. Show all 23 trades
This reflects the filings imported so far, not a complete trading history.